Muscle Pharm Corporation (MSLPQ)

[StocksAnonymous]

Year-to-date, MusclePharm has actually reported an operating loss of $2,976,893, offset by a one-time $5,264,854 bargain purchase gain relating to the acquisition of BioZone earlier this year. Backing out the effects of the bargain purchase gain, YTD EPS would be -$0.22, which for comparative purposes is substantially less than the $2.07 loss incurred over the same period a year ago.

Donald Prosser from the Q3 Call concerning Full Year FY14 guidance:

Well I think if you look at the EPS, again I think so - we’re really back to what we originally said that we were going to do for the year. I think we are cautiously optimistic after a very strong start, but again as Brad mentioned earlier we’re going to continue to invest where we see long-term gains and not try and just make a quarter and that’s what we’ve done. So I think we’re in that $0.20 to $0.25 range.

So including the "blue sky bargain purchase gain" (as you call it), their EPS to date for FY14 is .17. This implies that they are on track for a roughly break even Q4.

Do you honestly believe the company as of Dec. 31 2014 wasn't better off than the company was as of Dec. 31 2013?